These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33238276)

  • 1. Glomerular Neovascularization in Nondiabetic Renal Allograft Is Associated with Calcineurin Inhibitor Toxicity.
    Sawada A; Okumi M; Horita S; Unagami K; Taneda S; Fuchinoue S; Ishida H; Hattori M; Tanabe K; Nitta K; Koike J; Nagashima Y; Shimizu A
    Nephron; 2020; 144 Suppl 1():37-42. PubMed ID: 33238276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early histologic lesions and risk factors for recurrence of diabetic kidney disease after kidney transplantation.
    Nyumura I; Honda K; Tanabe K; Teraoka S; Iwamoto Y
    Transplantation; 2012 Sep; 94(6):612-9. PubMed ID: 23001327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of primary diabetic nephropathy on arteriolar hyalinosis lesions in patients following kidney transplantation.
    Yamakawa T; Kobayashi A; Yamamoto I; Kawaguchi T; Imasawa T; Aoyama H; Akutsu N; Maruyama M; Saigo K; Yokoo T; Kitamura H
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():70-75. PubMed ID: 29968417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts.
    Miura M; Higashiyama H; Fukasawa Y; Itoh Y; Tamaki T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():58-60. PubMed ID: 26031588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.
    Shimizu M; Furuichi K; Toyama T; Yamanouchi M; Hoshino J; Kitajima S; Hara A; Iwata Y; Sakai N; Yuzawa Y; Kitamura H; Sato H; Shibagaki Y; Suzuki Y; Uesugi N; Ueda Y; Kohagura K; Samejima K; Tsuruya K; Nishi S; Nishino T; Makino H; Matsuo S; Ubara Y; Yokoyama H; Wada T;
    J Diabetes Investig; 2023 Nov; 14(11):1268-1278. PubMed ID: 37483063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of diabetic kidney disease in a type 1 diabetic patient after kidney transplantation.
    Nyumura I; Honda K; Babazono T; Horita S; Murakami T; Fuchinoue S; Uchigata Y
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():90-2. PubMed ID: 26031596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interlobular hyaline arteriopathy reflects severe arteriolopathy in renal allografts.
    Oguchi H; Sakai K; Yamaguchi Y; Mikami T; Nemoto T; Ohashi Y; Kawamura T; Muramatsu M; Itabashi Y; Shinoda K; Hyodo Y; Takahashi Y; Kawaguchi Y; Onishi H; Hamasaki Y; Shibuya K; Shishido S
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():58-62. PubMed ID: 29968404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neovascularization at the vascular pole region in diabetic glomerulopathy.
    Osterby R; Asplund J; Bangstad HJ; Nyberg G; Rudberg S; Viberti GC; Walker JD
    Nephrol Dial Transplant; 1999 Feb; 14(2):348-52. PubMed ID: 10069187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet CD61 expression in vascular calcineurin inhibitor toxicity of renal allografts.
    Meehan SM; Baliga R; Poduval R; Chang A; Kadambi PV
    Hum Pathol; 2008 Apr; 39(4):550-6. PubMed ID: 18234279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 12. The Cytochrome P450 3A5 Non-Expressor Kidney Allograft as a Risk Factor for Calcineurin Inhibitor Nephrotoxicity.
    Udomkarnjananun S; Townamchai N; Chariyavilaskul P; Iampenkhae K; Pongpirul K; Sirichindakul B; Panumatrassamee K; Vanichanan J; Avihingsanon Y; Eiam-Ong S; Praditpornsilpa K
    Am J Nephrol; 2018; 47(3):182-190. PubMed ID: 29539600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing donor-transmitted diabetic kidney disease in kidney transplant recipients with fair sugar control: a single center retrospective study.
    Hsu CT; Wen MC; Chiu HF; Tsai SF; Yu TM; Yang CK; Wu MJ; Chen CH
    BMC Nephrol; 2020 Nov; 21(1):458. PubMed ID: 33143634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
    Horike K; Takeda A; Yamaguchi Y; Ogiyama Y; Yamauchi Y; Murata M; Kawaguchi T; Suzuki T; Otsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():23-7. PubMed ID: 21623910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion to Everolimus in Kidney Transplant Recipients With Calcineurin Inhibitor-Induced Nephropathy: 3 Case Reports.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Yagisawa T
    Transplant Proc; 2019 Jun; 51(5):1424-1427. PubMed ID: 31060742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of steroid-free low concentration calcineurin inhibitor maintenance immunosuppression regimen on renal allograft histopathology and function.
    Nainani N; Patel N; Tahir N; Kumar R; Weber-Shrikant E; Gundroo AA; Murray BM; Tornatore KM; Blessios GA; Venuto RC
    Nephrol Dial Transplant; 2012 May; 27(5):2077-83. PubMed ID: 22058172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasa recta hyalinosis reflects severe arteriolopathy in renal allografts.
    Oguchi H; Sakai K; Yamaguchi Y; Mikami T; Nemoto T; Ohashi Y; Kawamura T; Muramatsu M; Itabashi Y; Shinoda K; Hyodo Y; Takahashi Y; Kawaguchi Y; Onishi H; Hamasaki Y; Shibuya K; Shishido S
    Clin Exp Nephrol; 2019 Jun; 23(6):799-806. PubMed ID: 30734165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus.
    Mauer SM; Barbosa J; Vernier RL; Kjellstrand CM; Buselmeier TJ; Simmons RL; Najarian JS; Goetz FC
    N Engl J Med; 1976 Oct; 295(17):916-20. PubMed ID: 787786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
    Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants.
    Rodriguez Cubillo B; Rodriguez B; Calvo M; de la Manzanara V; Bautista J; Perez-Flores I; Calvo N; Moreno A; Shabaka A; Delgado J; Sanchez-Fructuoso AI
    Transplant Proc; 2016 Nov; 48(9):2956-2958. PubMed ID: 27932117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.